Author

C. Correa Giron

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:protein structure· 1

Frequent Co-Authors

A. Laaksonen· 2 shared F. L. Barroso da Silva· 2 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiophysics

A. Laaksonen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies

C. Correa Giron, A. Laaksonen, F. L. Barroso da Silva

This paper uses simulations to compare Omicron and other SARS-CoV-2 variants' RBD interactions with ACE2 and mAbs, identifying binding affinities and potential therapeutic targets.

bioRxiv · Jan 29, 2022Biophysics

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2

C. Correa Giron, A. Laaksonen, F. L. Barroso da Silva

This study maps electrostatic epitopes and interaction energies of SARS-CoV-1 and SARS-CoV-2 RBD proteins with antibodies and ACE2, showing higher ACE2 binding affinity for SARS-CoV-2 RBD.

bioRxiv · Apr 5, 2020Biophysics